A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for treating cognitive symptoms in Parkinson’s disease, a condition currently ...
Michael J Fox has given an honest update on how he copes with Parkinson's disease. The star is best known for playing Marty ...
University of Southern California-led researchers have discovered the structural details of a brain receptor called GPR6, ...
Summary of findings from the study and speculations from previous research. (Nishiwaki et al., npj Parkinson's Disease, 2024) ...
SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...
The study findings showed increased risks of dementia for anticholinergic drugs overall and specifically for the ...
Pathogenic mutations in LRRK2 account for 4-5% of familial and 1-2% of sporadic Parkinson’s disease. 1,2 BIIB122 (DNL151) is a selective, central nervous system-penetrant small molecule inhibitor of ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...